Curcumin has been demonstrated in ovarian cancer cell lines and murine models to influence chemosensitization, hindering NF‐κB, Wnt/β‐catenin, AKT/mTOR/p70S6K pathways and reducing the expression of P‐glycoprotein to restore ovarian cancer drug sensitivity.111, 112. Here, RPS6KB1 is linked to ovarian cancer.